Principal Scientist
Pfizer
Chesterfield, Missouri
Mark Chipley is a Principal Scientist at Pfizer. For the past 10 years, Mark has worked in Analytical Research and Development developing assays for a wide range of biotherapeutics, such as mRNA, mAbs, ADCs, enzymes, and gene therapy viral vectors. Additionally, Mark is an analytical project lead for therapeutic drug candidates being evaluated in clinical trials. Prior to Pfizer, Mark worked as an enzyme quality control chemist at MilliporeSigma (previously Sigma-Aldrich).
Disclosure information not submitted.
Analytical Comparability of a Complex Medium-Sized Biotherapeutic
Tuesday, July 23, 2024
2:35 PM – 3:05 PM CST